Excellent Results For MS Drug "Plegridy"
Biogen Idec has just announced its final first year results of the Phase 3 trial of its relapsing-remitting multiple sclerosis Source: Health News
Continue Reading →Posted in: AICHC News
Leave a Comment (0) →
